| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0163-7827(92)90006-5 |
| P698 | PubMed publication ID | 1461917 |
| P2093 | author name string | S. Parthasarathy | |
| S. M. Rankin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| P304 | page(s) | 127-143 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Progress in Lipid Research | Q15757018 |
| P1476 | title | Role of oxidized low density lipoprotein in atherogenesis | |
| P478 | volume | 31 |
| Q35064519 | Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry |
| Q73712824 | Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy |
| Q34504205 | Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids |
| Q41313864 | Antioxidant effect of flavonoids |
| Q77508105 | Antioxidant properties of ticlopidine on human low density lipoprotein oxidation |
| Q34157921 | Antioxidant: a new role for RU-486 and related compounds |
| Q41154173 | Antioxidants, atherosclerosis and thrombosis. |
| Q37628580 | B cells interactions in lipid immune responses: implications in atherosclerotic disease |
| Q56608865 | Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress |
| Q40642226 | Different mechanisms of adhesion molecule expression in human dermal microvascular endothelial cells by xanthoma tissue-mediated and copper-mediated oxidized low density lipoproteins |
| Q21285000 | Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery |
| Q44524051 | Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification |
| Q74562190 | Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation |
| Q33649831 | Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions |
| Q73397415 | Endothelial cell monolayer dysfunction caused by oxidized low density lipoprotein: attenuation by oleic acid |
| Q35207804 | Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's |
| Q47925617 | Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects |
| Q28389691 | Generation and biological activities of oxidized phospholipids |
| Q43906231 | Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients |
| Q33911138 | Is alcohol beneficial or harmful for cardioprotection? |
| Q33685117 | Lipid peroxidation and atherosclerosis in type II diabetes |
| Q24608256 | Liver x receptors in atherosclerosis and inflammation |
| Q47739528 | Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein |
| Q41039459 | Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands |
| Q41215819 | Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926. |
| Q41063669 | Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario |
| Q40896295 | Oxidized LDL and antioxidants |
| Q44208566 | Oxidized LDL metabolites with high family risk for premature cardiovascular disease |
| Q41369666 | Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. |
| Q74459557 | Panax quinquefolium saponins protects low density lipoproteins from oxidation |
| Q40343992 | Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases |
| Q42068195 | Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper |
| Q38345128 | Regulation of human apolipoprotein A-I gene expression by gramoxone |
| Q34741539 | Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins |
| Q73814083 | Role of chronic exercise in decreasing oxidized LDL-potentiated platelet activation by enhancing platelet-derived no release and bioactivity in rats |
| Q41449793 | Stress proteins and atherosclerosis |
| Q41382271 | Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells |
| Q34853745 | The Role of Obesity in Preeclampsia |
| Q77988260 | The importance of lipid solubility in antioxidants and free radical generating systems for determining lipoprotein proxidation |
| Q36846068 | The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics |
| Q77983950 | The role of oxidized HDL in monocyte/macrophage functions in the pathogenesis of atherosclerosis in Rhesus monkeys |
| Q34987443 | Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries |
| Q33607440 | Why are low-density lipoproteins atherogenic? |
Search more.